Literature DB >> 1499221

Use of the Pavlik harness for hip displacements. When to abandon treatment.

I E Harris1, R Dickens, M B Menelaus.   

Abstract

Seven hundred twenty congenitally dislocated or subluxated hips in 550 patients less than one year old, treated with the Pavlik harness, were retrospectively reviewed. Overall, 11% of the hips proved irreducible by Pavlik harness treatment, 9% had dysplasia at the end of harness treatment, and 5% developed dysplasia by the age of two years two months (average). Fourteen percent of the hips positive for Ortolani's sign, 6% of the hips positive for Barlow's sign, and 2% of the congenitally subluxated hips required open or closed reduction followed by plaster hip spica immobilization. Avascular necrosis occurred in 0.7% of the hips treated with the Pavlik harness alone. Transient irritability with pain and limited motion of the hip occurred in 1% of the hips. The Pavlik harness is not appropriate for the larger child, most children older than eight months of age, the child in whom the examiner does not get an adequate sense of reduction, the hip that redislocates with the slightest adduction, and the hip that requires excessive flexion to maintain reduction. Pavlik harness treatment should be abandoned in favor of other methods if, after two to four weeks of use, abduction has not improved sufficiently to allow reduction, the hip has not reduced, or the hip remains unstable.

Entities:  

Mesh:

Year:  1992        PMID: 1499221

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  14 in total

1.  The creation of a Pavlik "hemi-harness" for a singly irreducible hip in bilateral dysplastic hips.

Authors:  Amit Atrey; Marcos Katchburian
Journal:  J Child Orthop       Date:  2009-12-22       Impact factor: 1.548

2.  Verification of hip reduction using anterior ultrasound scanning during Pavlik harness treatment of developmental dysplasia of the hip.

Authors:  Graeme S Carlile; Timothy Woodacre; Peter J Cox
Journal:  J Orthop       Date:  2014-09-26

3.  Indicators of successful use of the Pavlik harness in infants with developmental dysplasia of the hip.

Authors:  H Atalar; U Sayli; O Y Yavuz; I Uraş; H Dogruel
Journal:  Int Orthop       Date:  2006-04-07       Impact factor: 3.075

4.  To screen or not to screen? A decision analysis of the utility of screening for developmental dysplasia of the hip.

Authors:  Susan T Mahan; Jeffrey N Katz; Young-Jo Kim
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

5.  Successful Pavlik treatment in late-diagnosed developmental dysplasia of the hip.

Authors:  Michiel A J van de Sande; Frank Melisie
Journal:  Int Orthop       Date:  2012-06-12       Impact factor: 3.075

6.  Risk factors for avascular necrosis after closed reduction for developmental dysplasia of the hip.

Authors:  Mathew D Schur; Christopher Lee; Alexandre Arkader; Anthony Catalano; Paul D Choi
Journal:  J Child Orthop       Date:  2016-05-13       Impact factor: 1.548

7.  Pavlik Harness Disease Revisited: Does Prolonged Treatment of a Dislocated Hip in a Harness Adversely Affect the α Angle?

Authors:  Alex L Gornitzky; Emily K Schaeffer; Charles T Price; Wudbhav N Sankar
Journal:  J Pediatr Orthop       Date:  2018-07       Impact factor: 2.324

Review 8.  Developmental dysplasia of the hip: update of management.

Authors:  Alfonso Vaquero-Picado; Gaspar González-Morán; Enrique Gil Garay; Luis Moraleda
Journal:  EFORT Open Rev       Date:  2019-09-17

9.  The incidence of avascular necrosis following a cohort of treated developmental dysplasia of the hip in a single tertiary centre.

Authors:  Rahim Nawaz Hussain; Darius Rad; William John Watkins; Clare Carpenter
Journal:  J Child Orthop       Date:  2021-06-01       Impact factor: 1.548

10.  Education of parents in Pavlik harness application for developmental dysplasia of the hip using a validated simulated learning module.

Authors:  Kate E Gargan; Catharine S Bradley; Alexandra Maxwell; Joel Moktar; John H Wedge; M Lucas Murnaghan; Simon P Kelley
Journal:  J Child Orthop       Date:  2016-06-24       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.